Clinical Trial Update: A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 safety study evaluating a carfilzomib, cyclophosphamide, and dexamethasone regimen given before autologous stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)

Snippet

Sponsor: Criterium, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED